SCHEMBL370082

SCHEMBL370082

C=CCc1cc(N)ccc1C#N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.44
ALDH1A1 P00352 5/20 0.44
USP2 O75604 1/20 0.44
LMNA P02545 1/20 0.39
HPGD P15428 5/20 0.37
MAPT P10636 3/20 0.37
GABRA1 P14867 2/20 0.35
GABRB2 P47870 2/20 0.35
CYP1A2 P05177 3/20 0.35
CYP2C19 P33261 3/20 0.35
CYP2D6 P10635 2/20 0.35
CYP3A4 P08684 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
HSD17B10 Q99714 2/20 0.33
TP53 P04637 1/20 0.33
ALOX15 P16050 1/20 0.33
MDM4 O15151 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
GAA P10253 4/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2164753 0.81 XDH (0.44) KDM4EALDH1A1HPGDMAPTGABRA1
SCHEMBL9447454 0.80 AR (0.38) ALDH1A1LMNAGABRA1GABRB2L3MBTL1
SCHEMBL29135915 0.79 AR (0.41) ALDH1A1HPGDCYP3A4TP53ALOX15
SCHEMBL15321939 0.79 KDM4E (0.42) KDM4EALDH1A1USP2LMNAHPGD
SCHEMBL29135913 0.79 MAOB (0.46) GABRA1GABRB2MAOAMAOB
SCHEMBL1982932 0.77 KDM4E (0.52) KDM4EALDH1A1USP2LMNAHPGD
SCHEMBL13167760 0.77 KDM4E (0.47) KDM4EALDH1A1USP2LMNAHPGD
SCHEMBL14394001 0.77 KDM4E (0.47) KDM4EALDH1A1USP2LMNAHPGD
SCHEMBL30215694 0.76 KLF10 (0.38) GABRA1GABRB2
SCHEMBL29135911 0.76 POLB (0.59) KDM4EALDH1A1HPGDGABRA1GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593461-A1 COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION Bristol-Myers Squibb Company (US) 2013-05-22 EP disclosed
WO-2012009309-A1 COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION BRISTOL-MYERS SQUIBB COMPANY (US) 2012-01-19 WO disclosed